oseltamivir

North America

Canada (18)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
JAMP OSELTAMIVIR 30MG caps
Rx
oral
J05AH02
JAMP OSELTAMIVIR 75MG caps
Rx
oral
J05AH02
MAR-OSELTAMIVIR 30MG caps
Rx
oral
J05AH02
MAR-OSELTAMIVIR 45MG caps
Rx
oral
J05AH02
MAR-OSELTAMIVIR 75MG caps
Rx
oral
J05AH02
MINT-OSELTAMIVIR 30MG caps
Rx
oral
J05AH02
MINT-OSELTAMIVIR 75MG caps
Rx
oral
J05AH02
NAT-OSELTAMIVIR 30MG caps
Rx
oral
J05AH02
NAT-OSELTAMIVIR 45MG caps
Rx
oral
J05AH02
NAT-OSELTAMIVIR 6MG/ML powd for susp
Rx
oral
J05AH02
NAT-OSELTAMIVIR 75MG caps
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE CAPSULES 30MG caps
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE CAPSULES 45MG caps
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE CAPSULES 75MG caps
Rx
oral
J05AH02
TAMIFLU 30MG caps
Rx
oral
J05AH02
TAMIFLU 45MG caps
Rx
oral
J05AH02
TAMIFLU 6MG/ML powd for susp
Rx
oral
J05AH02
TAMIFLU CAPSULE 75MG caps
Rx
oral
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
JAMP OSELTAMIVIR 30MG caps
02497409
JAMP OSELTAMIVIR 75MG caps
02497425
MAR-OSELTAMIVIR 30MG caps
02497352
MAR-OSELTAMIVIR 45MG caps
02497360
MAR-OSELTAMIVIR 75MG caps
02497379
MINT-OSELTAMIVIR 30MG caps
02497441
MINT-OSELTAMIVIR 75MG caps
02497476
NAT-OSELTAMIVIR 30MG caps
02472635
NAT-OSELTAMIVIR 45MG caps
02472643
NAT-OSELTAMIVIR 6MG/ML powd for susp
02499894
NAT-OSELTAMIVIR 75MG caps
02457989
OSELTAMIVIR PHOSPHATE CAPSULES 30MG caps
02504006
OSELTAMIVIR PHOSPHATE CAPSULES 45MG caps
02504014
OSELTAMIVIR PHOSPHATE CAPSULES 75MG caps
02504022
TAMIFLU 30MG caps
02304848
TAMIFLU 45MG caps
02304856
TAMIFLU 6MG/ML powd for susp
02381842
TAMIFLU CAPSULE 75MG caps
02241472
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

United States (44)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
N
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
N
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
N
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
N
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
N
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
Y
Rx
oral
J05AH02
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
N
oral
J05AH02
TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION
N
oral
J05AH02
TAMIFLU EQ 30MG BASE caps
Y
Rx
oral
J05AH02
TAMIFLU EQ 45MG BASE caps
Y
Rx
oral
J05AH02
TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION
Y
Rx
oral
J05AH02
TAMIFLU EQ 75MG BASE caps
Y
Rx
oral
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
211823/1
ANDA
24-06-2019
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
209093/1
ANDA
17-05-2017
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
209438/1
ANDA
23-02-2018
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
208348/1
ANDA
09-01-2018
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
207211/1
ANDA
14-09-2017
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
212544/1
ANDA
20-05-2020
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
210157/1
ANDA
21-01-2021
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
202595/1
ANDA
03-08-2016
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
208578/1
ANDA
24-02-2017
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
209421/1
ANDA
08-06-2018
OSELTAMIVIR PHOSPHATE EQ 30MG BASE caps
212739/1
ANDA
04-03-2020
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
211823/2
ANDA
24-06-2019
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
209093/2
ANDA
17-05-2017
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
209438/2
ANDA
23-02-2018
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
208348/2
ANDA
09-01-2018
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
207211/2
ANDA
14-09-2017
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
212544/2
ANDA
20-05-2020
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
210157/2
ANDA
21-01-2021
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
202595/2
ANDA
03-08-2016
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
208578/2
ANDA
24-02-2017
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
209421/2
ANDA
08-06-2018
OSELTAMIVIR PHOSPHATE EQ 45MG BASE caps
212739/2
ANDA
04-03-2020
OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION
212784/1
ANDA
27-05-2020
OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION
208823/1
ANDA
31-10-2017
OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION
210186/1
ANDA
27-02-2018
OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION
208347/1
ANDA
20-02-2018
OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION
209113/1
ANDA
14-09-2017
OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION
211125/1
ANDA
27-02-2019
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
211823/3
ANDA
24-06-2019
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
209093/3
ANDA
17-05-2017
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
209438/3
ANDA
23-02-2018
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
208348/3
ANDA
09-01-2018
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
207211/3
ANDA
14-09-2017
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
212544/3
ANDA
20-05-2020
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
210157/3
ANDA
21-01-2021
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
202595/3
ANDA
03-08-2016
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
208578/3
ANDA
24-02-2017
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
209421/3
ANDA
08-06-2018
OSELTAMIVIR PHOSPHATE EQ 75MG BASE caps
212739/3
ANDA
04-03-2020
TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION
21246/1
NDA
14-12-2000
TAMIFLU EQ 30MG BASE caps
21087/3
NDA
02-07-2007
TAMIFLU EQ 45MG BASE caps
21087/2
NDA
02-07-2007
TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION
21246/2
NDA
21-03-2011
TAMIFLU EQ 75MG BASE caps
21087/1
NDA
27-10-1999
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Europe

Austria (7)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EBILFUMIN 30 MG caps, hard
Rx
-
J05AH02
EBILFUMIN 45 MG caps, hard
Rx
-
J05AH02
EBILFUMIN 75 MG caps, hard
Rx
-
J05AH02
TAMIFLU 30 MG caps, hard
Rx
-
J05AH02
TAMIFLU 45 MG caps, hard
Rx
-
J05AH02
TAMIFLU 6 MG/ML powd for oral susp
Rx
-
J05AH02
TAMIFLU 75 MG caps, hard
Rx
-
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EBILFUMIN 30 MG caps, hard
EU/1/14/915/001-002
22-05-2014
EBILFUMIN 45 MG caps, hard
EU/1/14/915/003-004
22-05-2014
EBILFUMIN 75 MG caps, hard
EU/1/14/915/005-007
22-05-2014
TAMIFLU 30 MG caps, hard
EU/1/02/222/003
19-09-2007
TAMIFLU 45 MG caps, hard
EU/1/02/222/004
19-09-2007
TAMIFLU 6 MG/ML powd for oral susp
EU/1/02/222/005
28-11-2011
TAMIFLU 75 MG caps, hard
EU/1/02/222/001
20-06-2002
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Belgium (8)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EBILFUMIN 30 MG caps, hard
10x
10x
-
-

oral
J05AH02
EBILFUMIN 45 MG caps, hard
10x
10x
-
-

oral
J05AH02
EBILFUMIN 75 MG caps, hard
10x
10x
-
-

oral
J05AH02
TAMIFLU 12 MG/ML powd for oral susp
30 g
-
oral
J05AH02
TAMIFLU 30 MG caps, hard
10x
Y
oral
J05AH02
TAMIFLU 45 MG caps, hard
10x
Y
oral
J05AH02
TAMIFLU 6 MG/ML powd for oral susp
13 g
-
oral
J05AH02
TAMIFLU 75 MG caps, hard
10x
Y
oral
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EBILFUMIN 30 MG caps, hard
10x
10x
EU/1/14/915/002
EU/1/14/915/001
CP
CP
EBILFUMIN 45 MG caps, hard
10x
10x
EU/1/14/915/004
EU/1/14/915/003
CP
CP
EBILFUMIN 75 MG caps, hard
10x
10x
EU/1/14/915/006
EU/1/14/915/005
CP
CP
TAMIFLU 12 MG/ML powd for oral susp
30 g
EU/1/02/222/002
CP
TAMIFLU 30 MG caps, hard
10x
EU/1/02/222/003
CP
TAMIFLU 45 MG caps, hard
10x
EU/1/02/222/004
CP
TAMIFLU 6 MG/ML powd for oral susp
13 g
EU/1/02/222/005
CP
TAMIFLU 75 MG caps, hard
10x
EU/1/02/222/001
CP
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
EBILFUMIN 30 MG caps, hard
10x
10x
EBILFUMIN 45 MG caps, hard
10x
10x
EBILFUMIN 75 MG caps, hard
10x
10x
TAMIFLU 12 MG/ML powd for oral susp
30 g
TAMIFLU 30 MG caps, hard
10x
TAMIFLU 45 MG caps, hard
10x
TAMIFLU 6 MG/ML powd for oral susp
13 g
TAMIFLU 75 MG caps, hard
10x
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Bosnia and Herzegovina (0)
No result.
Croatia (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EBILFUMIN -
-
Rx
-
J05AH02
TAMIFLU -
Y
Rx
-
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EBILFUMIN -
TAMIFLU -
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Czechia (13)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EBILFUMIN 30MG caps, hard
30MG 10
30MG 10
N
N
oral
J05AH02
EBILFUMIN 45MG caps, hard
45MG 10
45MG 10
N
N
oral
J05AH02
EBILFUMIN 75MG caps, hard
75MG 10
75MG 10
N
N
oral
J05AH02
OSELTAMIVIR MSN 30MG caps, hard
30MG 10
N
oral
J05AH02
OSELTAMIVIR MSN 45MG caps, hard
45MG 10
N
oral
J05AH02
OSELTAMIVIR MSN 75MG caps, hard
75MG 10
N
oral
J05AH02
SEGOSANA 30MG caps, hard
30MG 10
N
oral
J05AH02
SEGOSANA 45MG caps, hard
45MG 10
N
oral
J05AH02
SEGOSANA 75MG caps, hard
75MG 10
N
oral
J05AH02
TAMIFLU 30MG caps, hard
30MG 10
N
oral
J05AH02
TAMIFLU 45MG caps, hard
45MG 10
N
oral
J05AH02
TAMIFLU 6MG/ML powd for oral susp
6MG/ML 1X13G
N
oral
J05AH02
TAMIFLU 75MG caps, hard
75MG 10
Y
oral
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EBILFUMIN 30MG caps, hard
30MG 10
30MG 10
EU/1/14/915/001
EU/1/14/915/002
CP
CP
EBILFUMIN 45MG caps, hard
45MG 10
45MG 10
EU/1/14/915/003
EU/1/14/915/004
CP
CP
EBILFUMIN 75MG caps, hard
75MG 10
75MG 10
EU/1/14/915/005
EU/1/14/915/006
CP
CP
OSELTAMIVIR MSN 30MG caps, hard
30MG 10
42/ 473/18-C
MRP/DCP
OSELTAMIVIR MSN 45MG caps, hard
45MG 10
42/ 474/18-C
MRP/DCP
OSELTAMIVIR MSN 75MG caps, hard
75MG 10
42/ 475/18-C
MRP/DCP
SEGOSANA 30MG caps, hard
30MG 10
42/ 473/18-C
MRP/DCP
SEGOSANA 45MG caps, hard
45MG 10
42/ 474/18-C
MRP/DCP
SEGOSANA 75MG caps, hard
75MG 10
42/ 475/18-C
MRP/DCP
TAMIFLU 30MG caps, hard
30MG 10
EU/1/02/222/003
CP
TAMIFLU 45MG caps, hard
45MG 10
EU/1/02/222/004
CP
TAMIFLU 6MG/ML powd for oral susp
6MG/ML 1X13G
EU/1/02/222/005
CP
TAMIFLU 75MG caps, hard
75MG 10
EU/1/02/222/001
CP
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
EBILFUMIN 30MG caps, hard
30MG 10
30MG 10
0
0
EBILFUMIN 45MG caps, hard
45MG 10
45MG 10
0
0
EBILFUMIN 75MG caps, hard
75MG 10
75MG 10
0
0
OSELTAMIVIR MSN 30MG caps, hard
30MG 10
0
OSELTAMIVIR MSN 45MG caps, hard
45MG 10
0
OSELTAMIVIR MSN 75MG caps, hard
75MG 10
0
SEGOSANA 30MG caps, hard
30MG 10
0
SEGOSANA 45MG caps, hard
45MG 10
0
SEGOSANA 75MG caps, hard
75MG 10
0
TAMIFLU 30MG caps, hard
30MG 10
0
TAMIFLU 45MG caps, hard
45MG 10
0
TAMIFLU 6MG/ML powd for oral susp
6MG/ML 1X13G
0
TAMIFLU 75MG caps, hard
75MG 10
362,37
530,57
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Denmark (7)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EBILFUMIN 30 MG caps, hard
-
-
J05AH02
EBILFUMIN 45 MG caps, hard
-
-
J05AH02
EBILFUMIN 75 MG caps, hard
-
-
J05AH02
TAMIFLU 30 MG caps, hard
-
-
J05AH02
TAMIFLU 45 MG caps, hard
-
-
J05AH02
TAMIFLU 6 MG/ML powd for oral susp
-
-
J05AH02
TAMIFLU 75 MG caps, hard
-
-
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EBILFUMIN 30 MG caps, hard
28105293513
CP
22-05-2014
EBILFUMIN 45 MG caps, hard
28105293613
CP
22-05-2014
EBILFUMIN 75 MG caps, hard
28105293713
CP
22-05-2014
TAMIFLU 30 MG caps, hard
28104105907
CP
24-06-2012
TAMIFLU 45 MG caps, hard
28104106007
CP
24-06-2012
TAMIFLU 6 MG/ML powd for oral susp
28104868111
CP
24-06-2012
TAMIFLU 75 MG caps, hard
28103234001
CP
24-06-2012
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
EBILFUMIN 30 MG caps, hard
EBILFUMIN 45 MG caps, hard
EBILFUMIN 75 MG caps, hard
TAMIFLU 30 MG caps, hard
TAMIFLU 45 MG caps, hard
TAMIFLU 6 MG/ML powd for oral susp
TAMIFLU 75 MG caps, hard
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Finland (9)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EBILFUMIN 30 MG caps, hard
10x in blister
10x in tablet container
N
N
Rx
Rx
-
J05AH02
EBILFUMIN 45 MG caps, hard
10x in blister
10x in tablet container
N
N
Rx
Rx
-
J05AH02
EBILFUMIN 75 MG caps, hard
10x in blister
10x in tablet container
N
N
Rx
Rx
-
J05AH02
TAMIFLU 30 MG caps, hard
10x in blister
Y
Rx
-
J05AH02
TAMIFLU 45 MG caps, hard
10x in blister
Y
Rx
-
J05AH02
TAMIFLU 6 MG/ML powd for oral susp
65 ml in bottle
Y
Rx
-
J05AH02
TAMIFLU 75 MG caps, hard
10x in blister
Y
Rx
-
J05AH02
TAMIFLU 75 MG caps, hard
10x in blister
Y
Rx
-
J05AH02
TAMIFLU 75 MG caps, hard
10x in blister
Y
Rx
-
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EBILFUMIN 30 MG caps, hard
10x in blister
10x in tablet container
-
-
22-05-2014
22-05-2014
EBILFUMIN 45 MG caps, hard
10x in blister
10x in tablet container
-
-
22-05-2014
22-05-2014
EBILFUMIN 75 MG caps, hard
10x in blister
10x in tablet container
-
-
22-05-2014
22-05-2014
TAMIFLU 30 MG caps, hard
10x in blister
-
19-09-2007
TAMIFLU 45 MG caps, hard
10x in blister
-
19-09-2007
TAMIFLU 6 MG/ML powd for oral susp
65 ml in bottle
-
28-11-2011
TAMIFLU 75 MG caps, hard
10x in blister
PI
02-05-2019
TAMIFLU 75 MG caps, hard
10x in blister
PI
13-05-2015
TAMIFLU 75 MG caps, hard
10x in blister
-
20-06-2002
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Hungary (10)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EBILFUMIN 30 MG caps, hard
10x blister
10x hdpe container
N
N
Rx
Rx
-
J05AH02
EBILFUMIN 45 MG caps, hard
10x blister
10x hdpe container
N
N
Rx
Rx
-
J05AH02
EBILFUMIN 75 MG caps, hard
10x blister
10x hdpe container
Y
N
Rx
Rx
-
J05AH02
SEGOSANA 30 MG caps, hard
10x blister
N
Rx
-
J05AH02
SEGOSANA 45 MG caps, hard
10x blister
N
Rx
-
J05AH02
SEGOSANA 75 MG caps, hard
10x blister
N
Rx
-
J05AH02
TAMIFLU 30 MG caps, hard
10x blister
Y
Rx
oral
J05AH02
TAMIFLU 45 MG caps, hard
10x blister
Y
Rx
oral
J05AH02
TAMIFLU 6 MG/ML powd for oral susp
1x13g glass
N
Rx
oral
J05AH02
TAMIFLU 75 MG caps, hard
10x blister
Y
Rx
oral
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EBILFUMIN 30 MG caps, hard
10x blister
10x hdpe container
EU/1/14/915/001
EU/1/14/915/002
22-05-2014
22-05-2014
EBILFUMIN 45 MG caps, hard
10x blister
10x hdpe container
EU/1/14/915/004
EU/1/14/915/003
22-05-2014
22-05-2014
EBILFUMIN 75 MG caps, hard
10x blister
10x hdpe container
EU/1/14/915/005
EU/1/14/915/006
22-05-2014
22-05-2014
SEGOSANA 30 MG caps, hard
10x blister
OGYI-T-23663/01
15-04-2020
SEGOSANA 45 MG caps, hard
10x blister
OGYI-T-23663/02
15-04-2020
SEGOSANA 75 MG caps, hard
10x blister
OGYI-T-23663/03
15-04-2020
TAMIFLU 30 MG caps, hard
10x blister
EU/1/02/222/003
20-06-2002
TAMIFLU 45 MG caps, hard
10x blister
EU/1/02/222/004
20-06-2002
TAMIFLU 6 MG/ML powd for oral susp
1x13g glass
EU/1/02/222/005
20-06-2002
TAMIFLU 75 MG caps, hard
10x blister
EU/1/02/222/001
20-06-2002
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
EBILFUMIN 30 MG caps, hard
10x blister
10x hdpe container
0
0
0
0
0
0
0
0
EBILFUMIN 45 MG caps, hard
10x blister
10x hdpe container
0
0
0
0
0
0
0
0
EBILFUMIN 75 MG caps, hard
10x blister
10x hdpe container
0
0
0
0
0
0
0
0
SEGOSANA 30 MG caps, hard
10x blister
0
0
0
0
SEGOSANA 45 MG caps, hard
10x blister
0
0
0
0
SEGOSANA 75 MG caps, hard
10x blister
0
0
0
0
TAMIFLU 30 MG caps, hard
10x blister
0
0
0
0
TAMIFLU 45 MG caps, hard
10x blister
0
0
0
0
TAMIFLU 6 MG/ML powd for oral susp
1x13g glass
0
0
0
0
TAMIFLU 75 MG caps, hard
10x blister
0
0
0
0
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Iceland (8)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EBILFUMIN 30 MG caps, hard
N
Rx
-
J05AH02
EBILFUMIN 45 MG caps, hard
N
Rx
-
J05AH02
EBILFUMIN 75 MG caps, hard
N
Rx
-
J05AH02
TAMIFLU 12 MG/ML powd for oral susp
N
Rx
-
J05AH02
TAMIFLU 30 MG caps, hard
Y
Rx
-
J05AH02
TAMIFLU 45 MG caps, hard
Y
Rx
-
J05AH02
TAMIFLU 6 MG/ML powd for oral susp
N
Rx
-
J05AH02
TAMIFLU 75 MG caps, hard
N
Rx
-
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EBILFUMIN 30 MG caps, hard
22-05-2014
EBILFUMIN 45 MG caps, hard
22-05-2014
EBILFUMIN 75 MG caps, hard
22-05-2014
TAMIFLU 12 MG/ML powd for oral susp
15-07-2002
TAMIFLU 30 MG caps, hard
15-10-2007
TAMIFLU 45 MG caps, hard
15-10-2007
TAMIFLU 6 MG/ML powd for oral susp
28-11-2011
TAMIFLU 75 MG caps, hard
15-07-2002
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
EBILFUMIN 30 MG caps, hard
EBILFUMIN 45 MG caps, hard
EBILFUMIN 75 MG caps, hard
TAMIFLU 12 MG/ML powd for oral susp
TAMIFLU 30 MG caps, hard
1.902
1.902
TAMIFLU 45 MG caps, hard
1.903
1.903
TAMIFLU 6 MG/ML powd for oral susp
TAMIFLU 75 MG caps, hard
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Ireland (7)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EBILFUMIN 30 MG caps, hard
-
Rx
oral
J05AH02
EBILFUMIN 45 MG caps, hard
-
Rx
oral
J05AH02
EBILFUMIN 75 MG caps, hard
-
Rx
oral
J05AH02
TAMIFLU 30 MG caps, hard
Y
Rx
oral
J05AH02
TAMIFLU 45 MG caps, hard
N
Rx
oral
J05AH02
TAMIFLU 6 MG/ML powd for oral susp
N
Rx
oral
J05AH02
TAMIFLU 75 MG caps, hard
Y
Rx
oral
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EBILFUMIN 30 MG caps, hard
EU/1/14/915/001-002
22-05-2014
EBILFUMIN 45 MG caps, hard
EU/1/14/915/003-004
22-05-2014
EBILFUMIN 75 MG caps, hard
EU/1/14/915/005-006
22-05-2014
TAMIFLU 30 MG caps, hard
EU/1/02/222/003
TAMIFLU 45 MG caps, hard
EU/1/02/222/004
TAMIFLU 6 MG/ML powd for oral susp
EU/1/02/222/005
TAMIFLU 75 MG caps, hard
EU/1/02/222/001
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Lithuania (8)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EBILFUMIN 30 MG caps, hard
N10 blister
N10 container
Rx
Rx
oral
J05AH02
EBILFUMIN 45 MG caps, hard
N10 blister
N10 container
Rx
Rx
oral
J05AH02
EBILFUMIN 75 MG caps, hard
N10 blister
N10 container
Rx
Rx
oral
J05AH02
TAMIFLU 12 MG/ML powd for oral susp
30 g N1 bottle
Rx
oral
J05AH02
TAMIFLU 30 MG caps, hard
N10 blister
Rx
oral
J05AH02
TAMIFLU 45 MG caps, hard
N10 blister
Rx
oral
J05AH02
TAMIFLU 6 MG/ML powd for oral susp
13 g N1 bottle
Rx
oral
J05AH02
TAMIFLU 75 MG caps, hard
N10 blister
Rx
oral
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EBILFUMIN 30 MG caps, hard
N10 blister
N10 container
EU/1/14/915/001
EU/1/14/915/002
CP
CP
22-05-2014
22-05-2014
EBILFUMIN 45 MG caps, hard
N10 blister
N10 container
EU/1/14/915/004
EU/1/14/915/003
CP
CP
22-05-2014
22-05-2014
EBILFUMIN 75 MG caps, hard
N10 blister
N10 container
EU/1/14/915/005
EU/1/14/915/006
CP
CP
22-05-2014
22-05-2014
TAMIFLU 12 MG/ML powd for oral susp
30 g N1 bottle
EU/1/02/222/002
CP
20-06-2002
TAMIFLU 30 MG caps, hard
N10 blister
EU/1/02/222/003
CP
20-06-2002
TAMIFLU 45 MG caps, hard
N10 blister
EU/1/02/222/004
CP
20-06-2002
TAMIFLU 6 MG/ML powd for oral susp
13 g N1 bottle
EU/1/02/222/005
CP
20-06-2002
TAMIFLU 75 MG caps, hard
N10 blister
EU/1/02/222/001
CP
20-06-2002
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Malta (0)
No result.
Netherlands (14)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EBILFUMIN 30 MG caps, hard
-
Rx
-
J05AH02
EBILFUMIN 45 MG caps, hard
-
Rx
-
J05AH02
EBILFUMIN 75 MG caps, hard
-
Rx
-
J05AH02
OSELTAMIVIR ZENTIVA 30 MG caps, hard
-
Rx
oral
J05AH02
OSELTAMIVIR ZENTIVA 45 MG caps, hard
-
Rx
oral
J05AH02
OSELTAMIVIR ZENTIVA 75 MG caps, hard
-
Rx
oral
J05AH02
SEGOSANA 30 MG caps, hard
-
Rx
oral
J05AH02
SEGOSANA 45 MG caps, hard
-
Rx
oral
J05AH02
SEGOSANA 75 MG caps, hard
-
Rx
oral
J05AH02
TAMIFLU 12 MG/ML powd for oral susp
-
Rx
-
J05AH02
TAMIFLU 30 MG caps, hard
-
Rx
-
J05AH02
TAMIFLU 45 MG caps, hard
-
Rx
-
J05AH02
TAMIFLU 6 MG/ML powd for oral susp
-
Rx
-
J05AH02
TAMIFLU 75 MG caps, hard
-
Rx
-
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EBILFUMIN 30 MG caps, hard
EU/1/14/915
-
22-05-2014
EBILFUMIN 45 MG caps, hard
EU/1/14/915
-
22-05-2014
EBILFUMIN 75 MG caps, hard
EU/1/14/915
-
22-05-2014
OSELTAMIVIR ZENTIVA 30 MG caps, hard
RVG 124065
-
22-04-2020
OSELTAMIVIR ZENTIVA 45 MG caps, hard
RVG 124069
-
22-04-2020
OSELTAMIVIR ZENTIVA 75 MG caps, hard
RVG 124070
-
22-04-2020
SEGOSANA 30 MG caps, hard
RVG 124071
-
22-04-2020
SEGOSANA 45 MG caps, hard
RVG 124072
-
22-04-2020
SEGOSANA 75 MG caps, hard
RVG 124073
-
22-04-2020
TAMIFLU 12 MG/ML powd for oral susp
EU/1/02/222
-
20-06-2002
TAMIFLU 30 MG caps, hard
EU/1/02/222
-
19-09-2007
TAMIFLU 45 MG caps, hard
EU/1/02/222
-
19-09-2007
TAMIFLU 6 MG/ML powd for oral susp
EU/1/02/222
-
29-11-2011
TAMIFLU 75 MG caps, hard
EU/1/02/222
-
20-06-2002
Product
Pack
SPC
PIL
Company
EBILFUMIN 30 MG caps, hard
EBILFUMIN 45 MG caps, hard
EBILFUMIN 75 MG caps, hard
OSELTAMIVIR ZENTIVA 30 MG caps, hard
OSELTAMIVIR ZENTIVA 45 MG caps, hard
OSELTAMIVIR ZENTIVA 75 MG caps, hard
SEGOSANA 30 MG caps, hard
SEGOSANA 45 MG caps, hard
SEGOSANA 75 MG caps, hard
TAMIFLU 12 MG/ML powd for oral susp
TAMIFLU 30 MG caps, hard
TAMIFLU 45 MG caps, hard
TAMIFLU 6 MG/ML powd for oral susp
TAMIFLU 75 MG caps, hard
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Norway (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
TAMIFLU 30 MG caps, hard
1 x 10
-
Rx
oral
J05AH02
TAMIFLU 45 MG caps
10
-
Rx
oral
J05AH02
TAMIFLU 45 MG caps, hard
1 x 10
-
Rx
oral
J05AH02
TAMIFLU 75 MG caps, hard
10
-
Rx
oral
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
TAMIFLU 30 MG caps, hard
1 x 10
01-11-2009
TAMIFLU 45 MG caps
10
01-04-2020
TAMIFLU 45 MG caps, hard
1 x 10
15-08-2009
TAMIFLU 75 MG caps, hard
10
01-10-2002
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Poland (12)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EBILFUMIN 30 MG caps, hard
10 caps blister
10 caps container
-
-
Rx
-
J05AH02
EBILFUMIN 45 MG caps, hard
10 caps blister
10 caps container
-
-
Rx
-
J05AH02
EBILFUMIN 75 MG caps, hard
10 caps blister
10 caps container
-
-
Rx
-
J05AH02
SEGOSANA 30 MG caps, hard
10 caps
-
Rx
-
J05AH02
SEGOSANA 45 MG caps, hard
10 caps
-
Rx
-
J05AH02
SEGOSANA 75 MG caps, hard
10 caps
-
Rx
-
J05AH02
TAMIFLU 12 MG/ML powd for oral susp
1 bottle 100 ml
-
Rx
-
J05AH02
TAMIFLU 30 MG caps, hard
10 caps
-
Rx
-
J05AH02
TAMIFLU 45 MG caps, hard
10 caps
-
Rx
-
J05AH02
TAMIFLU 6 MG/ML powd for oral susp
1 bottle 100 ml
-
Rx
-
J05AH02
TAMIFLU 75 MG caps, hard
10 caps
-
Rx
-
J05AH02
TAMIVIL 75 MG tabs
10 tabs
2 tabs
20 tabs
30 tabs
-
-
-
-
Rx
Rx
Rx
Rx
-
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EBILFUMIN 30 MG caps, hard
10 caps blister
10 caps container
CP
CP
EBILFUMIN 45 MG caps, hard
10 caps blister
10 caps container
CP
CP
EBILFUMIN 75 MG caps, hard
10 caps blister
10 caps container
CP
CP
SEGOSANA 30 MG caps, hard
10 caps
25986
DCP
21-08-2025
SEGOSANA 45 MG caps, hard
10 caps
25987
DCP
21-08-2025
SEGOSANA 75 MG caps, hard
10 caps
25988
DCP
21-08-2025
TAMIFLU 12 MG/ML powd for oral susp
1 bottle 100 ml
CP
13-02-2020
TAMIFLU 30 MG caps, hard
10 caps
CP
TAMIFLU 45 MG caps, hard
10 caps
CP
TAMIFLU 6 MG/ML powd for oral susp
1 bottle 100 ml
CP
TAMIFLU 75 MG caps, hard
10 caps
CP
TAMIVIL 75 MG tabs
10 tabs
2 tabs
20 tabs
30 tabs
24700
24700
24700
24700
NP
NP
NP
NP
27-04-2023
27-04-2023
27-04-2023
27-04-2023
Product
Pack
SPC
PIL
Company
EBILFUMIN 30 MG caps, hard
10 caps blister
10 caps container
EBILFUMIN 45 MG caps, hard
10 caps blister
10 caps container
EBILFUMIN 75 MG caps, hard
10 caps blister
10 caps container
SEGOSANA 30 MG caps, hard
10 caps
SEGOSANA 45 MG caps, hard
10 caps
SEGOSANA 75 MG caps, hard
10 caps
TAMIFLU 12 MG/ML powd for oral susp
1 bottle 100 ml
TAMIFLU 30 MG caps, hard
10 caps
TAMIFLU 45 MG caps, hard
10 caps
TAMIFLU 6 MG/ML powd for oral susp
1 bottle 100 ml
TAMIFLU 75 MG caps, hard
10 caps
TAMIVIL 75 MG tabs
10 tabs
2 tabs
20 tabs
30 tabs
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Romania (8)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EBILFUMIN 30 MG caps
blister din PVC/PE/PVDC/Al x 10 caps
flac. x 10 caps
-
-
PRF
PRF
-
J05AH02
EBILFUMIN 45 MG caps
blister din PVC/PE/PVDC/Al x 10 caps
flac. x 10 caps
-
-
PRF
PRF
-
J05AH02
EBILFUMIN 75 MG caps
blister din PVC/PE/PVDC/Al x 10 caps
flac. x 10 caps
-
-
PRF
PRF
-
J05AH02
SEGOSANA 30 MG caps
blister din PVC-PE-PVdC/ Al x 10 capsule
-
PRF
-
J05AH02
SEGOSANA 45 MG caps
blister din PVC-PE-PVdC/ Al x 10 capsule
-
PRF
-
J05AH02
SEGOSANA 75 MG caps
blister din PVC-PE-PVdC/ Al x 10 capsule
-
PRF
-
J05AH02
TAMIFLU 30 MG caps
x 1 blister PVC/PE/PVDC/Al x 10 capsule
-
PRF
-
J05AH02
TAMIFLU 75 MG caps
x 1 blister PVC/PE/PVDC/Al x 10 capsule
-
PRF
-
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EBILFUMIN 30 MG caps
blister din PVC/PE/PVDC/Al x 10 caps
flac. x 10 caps
-
-
EBILFUMIN 45 MG caps
blister din PVC/PE/PVDC/Al x 10 caps
flac. x 10 caps
-
-
EBILFUMIN 75 MG caps
blister din PVC/PE/PVDC/Al x 10 caps
flac. x 10 caps
-
-
SEGOSANA 30 MG caps
blister din PVC-PE-PVdC/ Al x 10 capsule
-
SEGOSANA 45 MG caps
blister din PVC-PE-PVdC/ Al x 10 capsule
-
SEGOSANA 75 MG caps
blister din PVC-PE-PVdC/ Al x 10 capsule
-
TAMIFLU 30 MG caps
x 1 blister PVC/PE/PVDC/Al x 10 capsule
-
TAMIFLU 75 MG caps
x 1 blister PVC/PE/PVDC/Al x 10 capsule
-
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Slovenia (5)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
TAMIFLU 12 MG/ML powd for oral susp
stekleničko 30 g powd, plastičnim nastav
N
Rx
oral
J05AH02
TAMIFLU 30 MG caps, hard
10 caps (1 x 10 caps blister)
N
Rx
oral
J05AH02
TAMIFLU 45 MG caps, hard
10 caps (1 x 10 caps blister)
N
Rx
oral
J05AH02
TAMIFLU 75 MG caps, hard
10 caps (1 x 10 caps blister)
N
Rx
oral
J05AH02
TAMIFLU 75 MG - BLAGOVNE REZERVE caps, hard
10 caps (1 x 10 caps blister)
-
Rx
oral
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
TAMIFLU 12 MG/ML powd for oral susp
stekleničko 30 g powd, plastičnim nastav
EU/1/02/222/002
CP
23-04-2012
TAMIFLU 30 MG caps, hard
10 caps (1 x 10 caps blister)
EU/1/02/222/003
CP
23-04-2012
TAMIFLU 45 MG caps, hard
10 caps (1 x 10 caps blister)
EU/1/02/222/004
CP
23-04-2012
TAMIFLU 75 MG caps, hard
10 caps (1 x 10 caps blister)
EU/1/02/222/001
CP
23-04-2012
TAMIFLU 75 MG - BLAGOVNE REZERVE caps, hard
10 caps (1 x 10 caps blister)
-
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
TAMIFLU 12 MG/ML powd for oral susp
stekleničko 30 g powd, plastičnim nastav
TAMIFLU 30 MG caps, hard
10 caps (1 x 10 caps blister)
5,35
TAMIFLU 45 MG caps, hard
10 caps (1 x 10 caps blister)
7,72
TAMIFLU 75 MG caps, hard
10 caps (1 x 10 caps blister)
10,12
TAMIFLU 75 MG - BLAGOVNE REZERVE caps, hard
10 caps (1 x 10 caps blister)
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Spain (7)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EBILFUMIN 30 MG caps, hard
10 caps
Y
Rx
oral
J05AH02
EBILFUMIN 75 MG caps, hard
10 caps
Y
Rx
oral
J05AH02
TAMIFLU 12 MG/ML powd for oral susp
1 bottle of 75 ml
-
Rx
oral
J05AH02
TAMIFLU 30 MG caps, hard
10 caps
Y
Rx
oral
J05AH02
TAMIFLU 45 MG caps, hard
10 caps
Y
Rx
oral
J05AH02
TAMIFLU 6 MG/ML powd for oral susp
1 bottle of 65 ml
Y
Rx
oral
J05AH02
TAMIFLU 75 MG caps, hard
10 caps
Y
Rx
oral
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EBILFUMIN 30 MG caps, hard
10 caps
1140915001
08-06-2020
EBILFUMIN 75 MG caps, hard
10 caps
1140915005
15-06-2020
TAMIFLU 12 MG/ML powd for oral susp
1 bottle of 75 ml
02222002
29-07-2002
TAMIFLU 30 MG caps, hard
10 caps
02222003
05-10-2007
TAMIFLU 45 MG caps, hard
10 caps
02222004
05-10-2007
TAMIFLU 6 MG/ML powd for oral susp
1 bottle of 65 ml
02222005
20-03-2012
TAMIFLU 75 MG caps, hard
10 caps
02222001
29-07-2002
Product
Pack
SPC
PIL
Company
EBILFUMIN 30 MG caps, hard
10 caps
EBILFUMIN 75 MG caps, hard
10 caps
TAMIFLU 12 MG/ML powd for oral susp
1 bottle of 75 ml
TAMIFLU 30 MG caps, hard
10 caps
TAMIFLU 45 MG caps, hard
10 caps
TAMIFLU 6 MG/ML powd for oral susp
1 bottle of 65 ml
TAMIFLU 75 MG caps, hard
10 caps
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Sweden (8)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EBILFUMIN 30 MG caps, hard
Rx
-
J05AH02
EBILFUMIN 45 MG caps, hard
Rx
-
J05AH02
EBILFUMIN 75 MG caps, hard
Rx
-
J05AH02
TAMIFLU 12 MG/ML powd for oral susp
Rx
-
J05AH02
TAMIFLU 30 MG caps, hard
Rx
-
J05AH02
TAMIFLU 45 MG caps, hard
Rx
-
J05AH02
TAMIFLU 6 MG/ML powd for oral susp
Rx
-
J05AH02
TAMIFLU 75 MG caps, hard
Rx
-
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EBILFUMIN 30 MG caps, hard
CP
22-05-2014
EBILFUMIN 45 MG caps, hard
CP
22-05-2014
EBILFUMIN 75 MG caps, hard
CP
22-05-2014
TAMIFLU 12 MG/ML powd for oral susp
CP
20-06-2002
08-10-2019
TAMIFLU 30 MG caps, hard
CP
19-09-2007
TAMIFLU 45 MG caps, hard
CP
19-09-2007
TAMIFLU 6 MG/ML powd for oral susp
CP
28-11-2011
TAMIFLU 75 MG caps, hard
CP
20-06-2002
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Switzerland (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
TAMIFLU 30 MG caps
-
B
-
J05AH02
TAMIFLU 45 MG caps
-
B
-
J05AH02
TAMIFLU 6 MG/ML Pulver zur Herstellung einer Suspension zum Einnehmen
-
B
-
J05AH02
TAMIFLU 75 MG caps
-
B
-
J05AH02
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
TAMIFLU 30 MG caps
55196 2
Hauptzulassung
21-09-1999
TAMIFLU 45 MG caps
55196 3
Hauptzulassung
21-09-1999
TAMIFLU 6 MG/ML Pulver zur Herstellung einer Suspension zum Einnehmen
56176 2
Hauptzulassung
02-02-2004
01-02-2024
TAMIFLU 75 MG caps
55196 1
Hauptzulassung
21-09-1999
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.